Rajiv Patni

Rajiv Patni discloses dealings in 4 companies, chiefly Adamas Pharmaceuticals Inc, Reata Pharmaceuticals Inc and Ocera Therapeutics, Inc. In total, 11 filings cover trades dated from 7 May 2015 to 26 September 2023.

In open-market terms, that means 1 purchase worth €18k on one side and 3 sales worth €55k on the other. Netting one side against the other leaves €37k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants.

On 26 September 2023 came the latest disclosure, a transaction in Reata Pharmaceuticals Inc. The latest purchase dates back some time: it was published 4,204 days ago, on 7 May 2015. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.